 "Cadila Healthcare hits record high on strong Q2 results")
Cadila Healthcare has rallied 5% to Rs 454, also its record high on the BSE in early morning trade, after reporting a strong 40% year on year (YoY) growth in consolidated net profit at Rs 391 crore for the quarter ended September 30, 2015 (Q2). The pharmaceutical company had profit of Rs 278 crore in a year ago quarter.
Its total income has increased by 17% at Rs 2,460 crore on YoY basis.
Earnings before interest, tax, depreciation and amortization (EBITDA) margin improved to 25.3% in September quarter from 19.97% in the corresponding quarter of previous fiscal.
During the quarter, the company’s business in US posted sales of Rs 1,004 crore registering a growth of 25%. The company received approval for one new product from the USFDA and two products were launched in the US market, Cadila Healthcare said in a release.
At 09:21 am, the stock was up 2.6% at Rs 443 on the BSE. A combined 579,730 shares changed hands on the counter on the BSE and NSE.
Its total income has increased by 17% at Rs 2,460 crore on YoY basis.
Earnings before interest, tax, depreciation and amortization (EBITDA) margin improved to 25.3% in September quarter from 19.97% in the corresponding quarter of previous fiscal.
During the quarter, the company’s business in US posted sales of Rs 1,004 crore registering a growth of 25%. The company received approval for one new product from the USFDA and two products were launched in the US market, Cadila Healthcare said in a release.
At 09:21 am, the stock was up 2.6% at Rs 443 on the BSE. A combined 579,730 shares changed hands on the counter on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%